Sort
34,240 grants matching “atherosclerosis”
Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins
$635,000Steven R Cummings · California Pacific Med Ctr Res Institute · R01 · FY2016 · AG
Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins
$635,000Steven R Cummings · California Pacific Med Ctr Res Institute · R01 · FY2019 · AG
Targeted therapy to reverse aortic aneurysms
$634,951Naren R. Vyavahare · Clemson University · R01 · FY2024 · HL
A Neurobehavioral Family Study of Schizophrenia
$634,937University Of Pennsylvania · R01 · FY2003 · MH
Role of the Gut Microbiota in Abdominal Aortic Aneurysm
$634,924Albert Phillip Owens III · University Of Cincinnati · R01 · FY2022 · HL
Role of the Gut Microbiota in Abdominal Aortic Aneurysm
$634,924Albert Phillip Owens III · University Of Cincinnati · R01 · FY2023 · HL
CD40 monocyte in chronic kidney disease
$634,794Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2018 · DK
CD40 monocyte in chronic kidney disease
$634,794Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2017 · DK
CD40 monocyte in chronic kidney disease
$634,794Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2019 · DK
CD40 monocyte in chronic kidney disease
$634,794Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2021 · DK
A critical role for macrophage ferroptosis in promoting fungal invasion in lung transplant recipients
$634,716Joe L Hsu · Stanford University · R01 · FY2022 · HL
Systems genomics of metabolic syndrome traits
$634,617Paivi Pajukanta · University Of California Los Angeles · P01 · FY2015 · HL
CSDE1 as a Post Transcriptional Regulator of the LDLR
$634,589John S Chorba · University Of California, San Francisco · R01 · FY2021 · HL
Modulating macrophage function in atherosclerosis by functionalized nanoparticles
$634,543Shobha Ghosh · Virginia Commonwealth University · R01 · FY2020 · HL
Modulating macrophage function in atherosclerosis by functionalized nanoparticles
$634,543Shobha Ghosh · Virginia Commonwealth University · R01 · FY2019 · HL
Modulating Macrophage Function in Atherosclerosis by Functionalized Nanoparticles
$634,543Hu Yang · Missouri University Of Science & Technology · R01 · FY2021 · HL
Sensing Vulnerable Plaque in vivo by an All-optical Intravascular Ultrasound and Photoacoustic Catheter
$634,489Ji-Xin Cheng · Boston University (Charles River Campus) · R01 · FY2021 · HL
Social Stressors and Atherosclerosis in African-American Women with Lupus
$634,451Tenã T Lewis · Emory University · R01 · FY2020 · AR
Epigenetic Mechanisms of PM-Mediated CVD Risk
$634,442Eric A. Whitsel · Univ Of North Carolina Chapel Hill · R01 · FY2014 · ES
Transvenous Optoacoustic-Ultrasound Guided Cold Laser Wire for Crossing Coronary Chronic Total Occlusion
$634,363Thomas E. Milner · University Of California-Irvine · R01 · FY2022 · HL
POSITRON TOMOGRAPHY IN ISCHEMIC HEART DISEASE
$634,351University Of California Los Angeles · R01 · FY2004 · HL
Blood TG clearance and vascular biology
$634,166Ira Jay Goldberg · Nyu Long Island School Of Medicine · P01 · FY2023 · HL
BEST-CLI Trial-CCC-Lead
$634,074Matthew Thomas Menard · Brigham And Women'S Hospital · U01 · FY2016 · HL
Lipid raft therapy â a novel therapeutic approach for HIV-associated cardiometabolic co-morbidities
$634,030Michael Ilya Bukrinsky · George Washington University · R01 · FY2023 · HL
STROKE OUTCOME AND NEUROIMAGING OF INTRACRANIAL STENOSIS
$633,985Rhode Island Hospital (Providence, Ri) · R01 · FY2001 · NS